background: This study was designed to assess the impact of different ovarian tissue transplantation sites on the follicular pool and ovarian tissue integrity after short-term grafting, since there is no consensus in the literature as to the optimal grafting site in experimental models.
Introduction
Recent progress in oncology has significantly increased long-term survival rates of cancer patients. Unfortunately, cancer treatments such as chemo/radiotherapy can be very harmful to the ovaries, frequently resulting in loss of both endocrine and reproductive functions in women (Donnez and Bassil, 1998; Wallace et al., 2005) .
Several options may be considered to preserve their fertility: embryo cryopreservation, oocyte cryopreservation and ovarian tissue cryopreservation (Donnez et al., 2006) . Ovarian tissue cryopreservation is now being proposed in an increasing number of reproductive centers. This approach can be applied without delaying cancer treatment, and allows patients to recover their ovarian function when they have overcome their disease, and potentially conceive. Moreover, it can be proposed to prepubertal patients. The first reports on frozen-thawed ovarian tissue transplantation are promising. Seven live births have been achieved so far after orthotopic transplantation of cryopreserved ovarian tissue (Donnez et al., 2004; Meirow et al., 2005; Demeestere et al., 2007; Andersen et al., 2008; Silber et al., 2008; Piver et al., 2009) . Re-establishment of ovarian function has also been reported after transplantation to an orthotopic site (Donnez et al., 2006 Meirow et al., 2007; Rosendahl et al., 2008) or heterotopic site such as the subcutaneous (SC) space of the forearm, muscle or abdominal wall (Oktay et al., 2004) .
Although retransplantation of cryopreserved ovarian tissue has been shown to restore ovarian function in most cases, many unresolved issues remain and further experimental studies are required to optimize cryopreservation and grafting procedures (Donnez et al., 2006 and assess their safety (Meirow et al., 2007) .
Xenografting of human ovarian tissue to mice has proved to be an effective model to study ovarian function and follicle development in vivo Nottola et al., 2008; Van Eyck et al., 2009a, b) . Other objectives are evaluation of treatment gonadotoxicity, assessment of the risk of reimplanting malignant cells and optimization of cryopreservation and grafting protocols.
In the literature, a number of transplantation sites have been investigated for human ovarian tissue xenografting, including intraperitoneal (IP) Van Eyck et al., 2009a, b) , beneath the ovarian bursa (OB) (Dolmans et al., 2007) under the kidney capsule (Oktay et al., 1998; Hernandez-Fonseca et al., 2004; Gook et al., 2005; Wang et al., 2008) , intramuscular (IM) (Maltaris et al., 2007) and SC Schmidt et al., 2003; Kim et al., 2005; Schubert et al., 2008) , but the most appropriate site for adequate clinical application has not yet been clearly determined because of contradictory results (Aubard, 2003) .
Moreover, fundamental differences in experimental protocols, such as mouse strain, animal treatment (castration, hormonal supplementation) and tissue pretreatment, render comparisons between studies difficult.
The present study was designed to compare four xenografting sites for frozen-thawed human ovarian cortical strips (IP, OB, SC and IM space) within a well-defined experimental design. The aim of the study was to assess the impact of the grafting site on the follicular pool and on stromal tissue integrity by analyzing follicular density, population and proliferation, as well as fibrotic and necrotic surface areas.
As follicular alterations and damage to stromal cells occur during the first few days after transplantation Yang et al., 2008) , analyses were performed 7 and 21 days post-grafting. These 2 days were selected on the basis of recent oxymetric and reperfusion studies by Van Eyck et al. (2009a, b) , who demonstrated progressive reoxygenation and reperfusion of the graft from Day 5 onwards and stabilization of reoxygenation and reperfusion 21 days after grafting.
Materials and Methods

Collection of ovarian tissue
Use of human ovarian tissue was approved by the Institutional Review Board of the Université Catholique de Louvain and patients gave their written informed consent. Human ovarian tissue was obtained from eight patients (between 22 and 37 years of age, Table I ) undergoing laparoscopic surgery for benign gynecologic disease. The size of the biopsy was 15 × 15 mm 2 . Ovarian biopsies were immediately transported to the laboratory in Leibovitz L-15 medium (Gibco, Paisley, UK). The medullar part was removed and the cortical tissue was cut into strips of 10 × 4 mm 2 . Tissue strips were frozen as described below.
Freezing and thawing procedure
Human ovarian tissue was frozen and thawed as previously described (Gosden et al., 1994) . Cortical strips were suspended in cryoprotective solution, consisting of Leibovitz L-15 medium supplemented with 4 mg/ ml human serum albumin (Red Cross, Brussels, Belgium) and 1.5 mol/l DMSO (Sigma, St Louis, MO, USA) at 48C, and transferred to 2-ml cryogenic vials (Simport, Quebec City, QC, Canada) filled with cryoprotectant. The cryovials were placed in a programmable freezer (Kryo 10, Series III; Planer, Sunbury-on-Thames, UK) using the following program: (i) cooled from 0 to 288C at 228C/min; (ii) seeded manually; (iii) cooled to 2408 at 20.38C/min; (iv) cooled to 21408C at 2308C/min and transferred to liquid nitrogen (21968C) for storage. The cryovials were thawed at room temperature for 2 min and immersed in a water bath at 378C for another 2 min. cryoprotectant. The cortical strips were then cut into pieces of 2 × 3 mm 2 with a scalpel. One strip was fixed in 4% formaldehyde solution (frozen-thawed control).
Transplantation into nude mice
The guidelines for animal welfare were approved by the Committee on Animal Research of the Université Catholique de Louvain. Sixteen 7-week-old NMRI nu/nu female mice (Janvier, Uden, the Netherlands) were used for the study. The mice were housed in groups of five per cage, maintained at 288C under controlled sterile conditions, with a 12-h light/dark cycle and free access to an autoclaved pelleted diet and water. The mice were anesthetized by IP injection of ketamine (75 mg/kg; Eurovet, Heusden-Zolder, Belgium) and medetomidine (1 mg/kg; Pfizer, Cambridge, MA, USA), associated with buprenorphine (0.1 mg/kg; Temgesic, Schering-Plough, Kenilworth, NJ, USA) for analgesia.
Eight series of experiments were performed, with ovarian biopsies taken from eight patients. Ovarian tissue from each patient was then systematically grafted onto two mice at four different sites; for 7 days in one mouse and 21 days in the other. Strips of 2 × 3 mm 2 were placed in IP, SC and IM sites and, due to space restrictions, a strip of 1 × 2 mm 2 was inserted into the OB. Because of the smaller size of fragments grafted onto the OB, all parameters were evaluated relative to the volume of the graft. Mouse operations were carried out as illustrated in Fig. 1 . First, a laparotomy was performed on the left flank to insert an ovarian strip into the OB cavity using an operative microscope. A small slit was made in the OB membrane to place the ovarian cortical fragment, as previously described (Dolmans et al., 2007) . Then, a midline laparotomy was performed to graft one strip onto the peritoneum with 7/0 Prolene and one strip under the skin. Finally, an incision was made in the right thigh to place a strip into the muscle using 7/0 Prolene.
After surgery, anesthesia was reversed by IP injection of atipamezole (1 mg/kg; Pfizer, Brussels, Belgium).
Graft recovery
The animals were euthanized by cervical dislocation after 7 and 21 days and the grafts were recovered and fixed in 4% formaldehyde. Each graft, embedded in paraffin, was cut into serial sections of 5 mm. Every sixth section was stained with hematoxylin -eosin (Merck, Darmstadt, Germany) for histological analysis and the others were used for immunostaining (Superfrost Plus slides, Menzel-Glaser, Braunschweig, Germany).
Measurement of follicular density and follicle classification
Hematoxylin -eosin-stained slides were examined blindly by two independent observers (C.D. and L.D.V.) under a microscope (Zeiss, Munich, Germany) at ×400 magnification. All the follicles were counted and classified into six types according to Gougeon's classification (1986) : (i) primordial follicle, oocyte surrounded by a single layer of flattened pre-granulosa cells; (ii) intermediate follicle, oocyte surrounded by a single layer of flattened and cuboidal granulosa cells; (iii) primary follicle, oocyte showing a single layer of cuboidal granulosa cells; (iv) secondary follicle, with at least two complete layers of granulosa cells; (v) antral follicle, with development of an antral cavity. Atretic follicles were characterized by the presence of eosinophilia of the ooplasm, contraction and clumping of chromatin material, and wrinkling of the nuclear membrane of oocytes (Lass et al., 1997) . Only follicles with a visible nucleus were counted and follicular distribution was strictly analyzed at 30 mm intervals, ensuring that no pre-antral follicles were counted twice (Lass et al., 1997) . The whole ovarian graft was examined and follicular density was expressed as the number of follicles per cubic millimeter. Follicular densities were statistically compared between the four grafting sites. Follicle classification was used as a parameter to evaluate the capacity of each grafting site to sustain follicular growth (up to the secondary stage), as well as maintain a primordial follicle pool.
Measurement of proliferative activity
Proliferative activity was evidenced by immunostaining with anti-Ki-67 antibodies. Ki-67 is a nuclear antigen associated with cell proliferation and is present throughout the active cell cycle (late G1, S, G2 and M phases), but absent in resting cells (G0). Immunostaining was performed on several sections from the same graft, as previously described (Dolmans et al., 2007) .
Sections were deparaffinized with Histosafe (Yvsolab SA, Beerse, Belgium) and rehydrated in 2-propanol (Merck). Endogenous peroxidase activity was blocked by incubating the sections with 0.3% H 2 O 2 (Merck). The sections were decloaked in citrate buffer at 988C and incubated with goat serum to block non-specific binding sites. After overnight incubation with primary antibody (rabbit anti-Ki-67 human antibody: K1745 -25, 1:100, US Biological, Swampscott, MA, USA), the slides were incubated for 60 min at room temperature with secondary goat antirabbit antibody (HRP system, K4003, Dako, Glostrup, Denmark). Diaminobenzidine (Dako) was used as a chromogen and nuclei were counterstained with hematoxylin. Human proliferative endometrium was used as a positive control for Ki-67 labeling. Negative controls included sections incubated with normal rabbit IgGs (Dako) at the same concentration as the primary antibody.
The proliferation index was evaluated blindly by two observers (C.D. and A.S.V.E.) as the percentage of follicles with Ki-67-positive granulosa cells for each class of follicle. Follicles with at least one Ki-67-stained granulosa cell were considered to have initiated growth (Gougeon and Busso, 2000; Oktay et al., 2000) . Results were analyzed according to graft site and duration.
Analysis of fibrosis and necrosis
Relative areas of fibrosis and necrosis were evaluated on one central hematoxylin -eosin-stained section.
Fibrotic areas were characterized by poor cellularity, as evidenced by a reduced number of cell nuclei and collagen deposits. This was confirmed by an objective and specific method, Masson's trichrome staining. Necrotic areas were characterized by the presence of pyknotic nuclei in stromal cells and signs of cytolysis, including the presence of cell debris and an empty cytoplasm.
Sections were analyzed field by field at ×100 magnification. Fields were digitized using a Leica DFC320 camera and IM50 program (Leica, Wetzlar, Germany). ImageJ, an image-processing and analysis program developed at the National Institutes of Health (http://rsb.info.nih.gov/ij/), was used to delimit fibrotic and necrotic areas, and total section areas. Evaluation was performed blindly by two independent observers (C.D. and L.D.V.) in both ovarian tissue grafts and corresponding non-grafted tissue. Results were expressed as fibrotic or necrotic areas relative to total section areas. As no significant difference was observed between the two evaluations, results were averaged.
Statistical analyses
Statistical analyses were carried out using the SPSS 14 program for Windows (SPSS Inc., Chicago, IL, USA). An intraclass correlation test was conducted to validate the double-blind procedure. To compare follicular densities and fibrotic surface areas according to grafting site and duration, the non-parametric Kruskal-Wallis test was applied for exploratory data analyses and the Mann -Whitney U-test was used for non-parametric independent two-group comparisons.
Follicular proliferation rate was compared between the selected grafting sites and durations by the x 2 test.
Values of at least P , 0.05 were considered statistically significant.
Results
Graft recovery rate and macroscopic aspect
Xenografts were removed after 7 or 21 days. The recovery rate was 100% for both the IP (16/16) and IM (16/16) sites, 88% for SC tissue (14/16) and 75% for the OB cavity (12/16). Seven days after grafting to IP, SC and IM sites, the fragments appeared whitish and the interface between the grafts and murine tissue was already invaded by vessels. After 21 days of grafting to IP and IM sites, the fragments showed a reddish color, with small vessels visible on the graft surface, and they were attached to the surrounding tissue.
Fragments grafted to the SC site remained white and less adherent, as did those recovered from the OB.
Follicular histology and density
Follicle morphology, as classified according to Gougeon's criteria, was well preserved in all four grafting sites both 7 and 21 days after grafting of frozen-thawed ovarian tissue (Gougeon, 1986) . Primordial and primary follicles in the grafted group were found to have the same features as those observed in non-grafted controls, appearing as regularly rounded structures with a single and complete layer of follicular cells, flattened (primordial) or cuboidal (primary) in shape, lying on a continuous basement membrane. Only a few atretic follicles were observed, as evidenced by the presence of condensed nuclear material and/or a dark ooplasm. Their numbers were very low and no statistical analysis was therefore conducted.
Follicular density (expressed as the total number of follicles per cubic millimeter) in ovarian tissue before grafting and 7 or 21 days after IP, OB, SC and IM transplantation is presented in Table I . Statistical dispersion was evaluated by the interquartile range and showed heterogeneous distribution of follicles in both grafted and non-grafted tissue. Huge variations in follicular density were observed from patient to patient, but no correlation was found according to patient age in non-grafted control tissue (R 2 ¼ 0.59). For this reason, a nonparametric test was performed to allow statistical analysis of density results. No significant difference in follicular density was evidenced between grafting sites or durations.
Follicle classification
Classification of the different follicular stages (primordial, intermediate, primary, secondary and antral) is shown in Table II , according to the grafting site and duration. One week after grafting, growing follicles were observed in all four sites and a few healthy-looking secondary follicles were identified. The mean proportion of primary follicles in 7-day grafts was 7, 33.3, 8.7 and 12% in the IP, OB, SC and IM sites, respectively, compared with 9.9% in non-grafted tissue. Follicles that had reached the secondary stage represented 1.6 -9.3% of the total number, versus 6.7% in non-grafted controls. Three weeks after grafting, 10.9, 16.7, 31.8 and 8.3% of follicles were at the primary stage in IP, OB, SC and IM grafts, respectively, and between 1.4 and 27.8% were at the secondary stage. Interestingly, after 21 days, primordial follicles constituting the follicular reserve represented 54.6, 38.8, 34.1 and 66.9% of the total follicle population in IP, OB, SC and IM grafts, respectively.
Follicular proliferation
The percentage of Ki-67-positive follicles was assessed to further evaluate follicular growth after grafting of frozen-thawed tissue. This proliferation marker is a more sensitive indicator of growth than morphology alone (Dolmans et al., 2007) . Figure 2 shows the follicular proliferation rate of primordial follicles according to the grafting site and duration. Seven days after grafting, there was a marked increase in the proportion of Ki-67-positive primordial follicles in IP (34.4%), OB (33.3%), SC (20%) and IM grafts (42%) compared with frozen-thawed tissue (1.7%) (P , 0.05), but no difference was observed according to grafting site. Follicular proliferation was also found to be enhanced 1 week post-transplantation in growing follicles, rising to 80, 62.5, 56.3 and 64.0% in IP, OB, SC and IM grafts, respectively, compared with 19.6% in non-grafted frozen-thawed tissue (P , 0.05).
Three weeks after grafting, most primordial follicles were quiescent, as only 4.3, 12.5 and 10% had initiated growth in IP, SC and IM grafts, respectively, with none in OB grafts. Their proportion was significantly lower than after 7 days in IP and IM grafts. For later-stage follicles (intermediate, primary and secondary), 42.5, 50, 17.6 and 30% of Ki-67-positive follicles were observed after 3 weeks in IP, OB, SC and IM grafts, respectively.
Morphometric analysis of stromal tissue necrosis and fibrosis
Only a few cells showed necrotic features in 1-week and 3-week xenografts, ranging from 3 to 6.5% of the total surface area. On the contrary, a marked increase in tissue fibrosis was observed in frozen-thawed grafted tissue compared with control tissue in all four grafting sites. Results of the morphometric analysis of fibrotic surface areas are shown in Fig. 3 . No fibrosis was detected in non-grafted control tissues, whereas a similar area of fibrosis was observed in all sites after 7 and 21 days of grafting. Three weeks after grafting, significant differences in relative fibrotic areas were found according to the transplantation site (P , 0.05, Kruskal -Wallis test). Relative fibrosis was significantly less pronounced in 3-week IM grafts compared with OB (P ¼ 0. Mann -Whitney test), as illustrated in Figs 3 and 4. Nevertheless, most follicles observed in fibrotic areas looked healthy.
Discussion
Murine xenotransplantation of human ovarian tissue is a wellestablished and widely used model. It has been applied to assess the risk of reimplanting malignant cells after human ovarian tissue retransplantation (Kim et al., 2001) . It is a useful experimental tool to evaluate the human follicular reserve after gonadotoxic treatment (Oktem and Oktay, 2007) . Several groups have used xenografting to analyze follicular developmental potential, oocyte quality and ovarian histology and function after cryopreservation and transplantation Gook et al., 2005; Kim et al., 2005; Schubert et al., 2008) . It is also a model of choice to investigate mechanisms underlying follicle activation and tissue revascularization and reoxygenation after grafting Van Eyck et al., 2009a, b) . Finally, it is an experimental tool to optimize cryopreservation protocols (Newton et al., 1996; Wang et al., 2008) and improve grafting conditions for future clinical application by investigating the impact of hormonal (Maltaris et al., 2007) and proangiogenic treatments. There is currently no consensus in the literature as to the optimal grafting site for frozen-thawed human ovarian tissue in murine xenotransplantation models. This prompted us to evaluate short-term outcomes after transplantation of ovarian tissue from a single patient to four grafting sites (IP, OB, SC and IM). The experiment was designed to compare the outcomes, at two-specific time points, of one ovarian Figure 3 Relative fibrotic area according to grafting site and duration. IP ¼ intraperitoneal, OB ¼ ovarian bursa, SC ¼ subcutaneous, IM ¼ intramuscular. The area of fibrosis did not differ between 7 and 21 days of grafting in any site. After 21 days, the percentage of fibrosis was significantly lower in tissue transplanted to muscle** compared with that transplanted to the pelvic cavity* or OB* (P , 0.05). Figure 4 Representative photomicrographs of frozen-thawed ovarian stromal tissue from the same patient before and after grafting to an IM or OB site for 7 and 21 days. A significant increase in fibrosis was observed in the OB graft compared with the IM graft. The extent of fibrosis was similar after 7 and 21 days in both sites. Scale bar ¼ 100 mm. In the inset, a growing follicle is shown in a fibrotic area (scale bar ¼ 40 mm).
Xenografting of human ovarian tissue biopsy transplanted to four different sites, in order to account for patient-to-patient variability in follicular density and distribution. Our objective was to evaluate ovarian tissue damage immediately after the critical hypoxic period, i.e. at 7 days post-grafting, and then again at 21 days, after tissue revascularization and reoxygenation (Van Eyck et al., 2009a, b) . Our previous studies showed IP human ovarian xenografts to be exposed to hypoxia during the first 5 days after transplantation, with grafts becoming gradually reoxygenated during the subsequent 5 days (Van Eyck et al., 2009a) , coinciding with graft reperfusion (Van Eyck et al., 2009b) .
All four transplantation sites yielded similar results in terms of follicular density, growth and morphology, and no statistical difference in density was evident. A non-parametric test was applied to account for patient-to-patient variability in follicle count. This was not found to be correlated with patient age in the present study and may be explained by the heterogeneous distribution of follicles in ovarian cortex Van den Broecke et al., 2001; Gook et al., 2005) . To draw any firm conclusions on follicular density, a larger number of samples should be analyzed. Nevertheless, the present study provides interesting information on follicular growth, maintenance of quiescent follicles and stromal fibrosis. One week after IP, OB, SC and IM grafting, strong activation of primordial follicle growth was observed, as demonstrated by a marked increase in Ki-67-positive follicles in all four sites, whereas 3 weeks after grafting, proliferation indices decreased. Another consequence of grafting was that extensive ovarian stromal tissue fibrosis observed in all four sites, although it was less pronounced in IM grafts after 3 weeks.
As previously reported, there is no obvious impact of freezing or transplantation procedures on follicular morphology Schubert et al., 2008) . Primordial follicles are thought to be particularly resistant to the freezing process and ischemic stress due to their low metabolic rate and because they normally develop within a relatively hypoxic environment (Gosden and Byatt-Smith, 1986) . Only a few atretic follicles were observed 7 days after grafting. However, one cannot exclude the occurrence of follicle apoptosis at earlier time points, followed by rapid recovery or clearance of damaged follicles, as observed after rat ovarian tissue transplantation (Israely et al., 2006; Yang et al., 2008) . In the present study, the most striking phenomenon after grafting was the massive increase in the proportion of Ki-67-positive follicles 7 days after grafting, observed in primordial as well as later-stage follicles in all four sites. Follicular proliferation was evidenced by Ki-67 immunostaining, which is a more sensitive indicator of growth than morphological classification between follicular stages (Dolmans et al., 2007) . This phenomenon of accelerated follicular growth has been reported to occur after transplantation Baird et al., 2004; Dolmans et al., 2007) and in vitro culture (Fortune, 2003; Telfer et al., 2008) , and the present findings appear to indicate that there is no major impact of the grafting site on post-grafting follicular activation. Several hypotheses have been proposed to explain this premature follicular cell activation. It may result from stimulation of granulosa cell growth by ischemic and oxidative stress, after transplantation, via hypoxia-inducible factor-1 Nottola et al., 2008) . On the other hand, the absence of antral follicles and lack of secondary follicles in grafted cortical fragments may disrupt the balance between stimulatory and inhibitory factors, thereby contributing to follicular activation. Indeed, production of inhibitory factors by antral follicles is thought to be important for the maintenance of quiescent follicles (Baird et al., 2004) . The massive follicular activation observed shortly after ovarian cortex grafting may lead to accelerated depletion of the reserve of non-growing follicles (Gougeon and Busso, 2000) . Fortunately, as evidenced in the present study, the increase in follicular growth observed after 7 days appears to be temporary. After 3 weeks of grafting, persistent primordial follicles, representing 54.6, 38.8, 34.1 and 66.9% of the total follicle population in IP, OB, SC and IM grafts, respectively, were quiescent, as confirmed by the absence of Ki-67 staining. These quiescent follicles constitute the pool of resting primordial follicles.
This pattern of follicular growth and the presence of morphologically intact follicles in fibrotic areas suggest that early follicular growth is not markedly affected by stromal tissue fibrosis. Nevertheless, molecular consequences and the long-term impact of stromal fibrosis on follicles are largely unknown. As stromal cells are recruited to form the follicular theca (Skinner, 2005) and may produce paracrine factors essential for folliculogenesis and ovulatory processes, impairment of stromal cells may have consequences for later-stage folliculogenesis and final maturation steps. Stromal cells are known to produce a number of factors, including members of the TGFb superfamily such as bone morphogenic protein-4 and -7, acting as paracrine signaling factors for follicular survival and development (Skinner, 2005; Knight and Glister, 2006) . The stroma is also likely to contribute to revascularization processes after grafting by producing angiogenic factors, as shown in the rat (Dissen et al., 1994) , and to regulation of vascular remodeling during the ovulatory cycle.
Stromal fibrosis occurring during the first few days after transplantation is likely to be a consequence of both the freezing process and post-transplantation ischemic stress. Slow-freezing protocols routinely applied for ovarian tissue cryopreservation have been shown to be deleterious to the stromal cell compartment, as demonstrated by an increase in fibrosis in frozen-thawed ovarian transplants compared with fresh grafts . Further, development of cryopreservation techniques is required to optimize outcomes after transplantation of frozen-thawed ovarian tissue in humans. Ovarian stromal fibrosis may also result from post-transplantation ischema -reperfusion injury. In the rat, Callejo et al. (2002) observed a greater degree of cortical fibrosis after SC and IP transplantation of fresh ovarian tissue. This damage may be due to ischemic stress in the interval between tissue collection and graft revascularization (Kim et al., 2004; Van Eyck et al., 2009a, b) . Moreover, a better vascularized transplantation site may promote faster revascularization of ovarian tissue, limiting the duration of ischemia and hence ovarian damage Callejo et al., 2002; Israely et al., 2006) . In our study, the IM site showed less extensive fibrosis than the other sites after 3 weeks, even the IP site, also known to be well vascularized. Indeed, graft surface area in contact with host tissue was greater in the IM site than the IP site. Fragments grafted to the IP site were fixed to the peritoneum by a single stitch, compared with fragments grafted to muscle, which were inserted into a space inside the muscle. Vascular analysis of the different sites could yield information about the relationship between fibrosis and graft revascularization, according to the grafting site.
A promising approach to protect stromal cells from ischemic damage is to treat ovarian tissue with a protective agent against hypoxic stress, as suggested in the study by Kim et al. (2004) on bovine ovarian cortical tissue.
The four investigated grafting sites were selected on the basis of previous experimental studies (IP: Nisolle et al., 2000; Van Eyck et al., 2009a, b; SC: Weissman et al., 1999; Nisolle et al., 2000; Kim et al., 2002; IM: Israely et al., 2006; Soleimani et al., 2008; OB: Dolmans et al., 2007) and/or human clinical application (Donnez et al., 2006; Demeestere et al., 2007; Kim et al., 2009 ). All four sites showed similar results in terms of supporting follicle development during the first 3 weeks after grafting and were found to be equally suitable for short-term ovarian tissue transplantation. However, one cannot exclude the possibility that recovery of ovarian function in one site could have an impact on other sites, even if such effects are likely to be limited in short-term grafts containing only pre-antral follicles. Further, studies are also required to assess whether results achieved in mice with intact ovaries hold true for castrated animals, as several reports suggest that the hormonal status of an animal may influence outcomes (Kim et al., 2005; Weissman et al., 1999) .
The OB cavity, a site typically used in rodent autotransplantation models (Deng et al., 2007) , proved to be an interesting xenotransplantation site for human ovarian tissue and isolated follicles (Dolmans et al., 2007) . However, grafting beneath the murine OB has several disadvantages compared with other sites. Only tissue pieces smaller than 1 × 2 mm 2 can be inserted into the bursa via a small slit under microscopic control, fragments are not fixed and a greater proportion of grafts may be lost. Moreover, in women, there is no anatomical equivalent of the murine OB, and the clinical ovarian grafting procedure (Meirow et al., 2005; Donnez et al., 2006; Andersen et al., 2008) wherein fragments are fixed to the ovary cannot be considered wholly comparable. The SC graft site, classically described as a poorly vascularized area, remains controversial (Demeestere et al., 2007; Andersen et al., 2008) . It has the advantage of entailing an easy surgical procedure and allowing external follow-up of follicular growth (Kim et al., 2009) . However, papers describing heterotopic autotransplantation always report follicular development of ,15 mm in size. The environment, pressure changes and temperature in the SC site might all be factors that contribute to this phenomenon (Donnez et al., 2006; Demeestere et al., 2009) .
The IM site appears to induce less fibrosis than other sites. However, more intense muscular activity in the hind limb possibly puts additional physical stress on the grafted tissue, which could be deleterious especially for late-growing follicles. Soleimani et al. (2008) recently described a grafting procedure to the back muscle in a mouse allograft model, which takes advantage of the rich angiogenic environment of an IM site, without the high level of muscular activity. Finally, the IP site may be the equivalent of the orthotopic graft site used for transplantation of ovarian tissue in humans (Donnez et al., 2004 (Donnez et al., , 2006 Demeestere et al., 2007; Andersen et al., 2008) . Indeed, it probably provides the most favorable environment for follicular development.
In conclusion, all four grafting sites equally supported early follicular growth after short-term transplantation of frozen-thawed human ovarian tissue. Although follicular activation was observed after IP, SC, IM and OB grafting, the pool of quiescent primordial follicles was not exhausted 3 weeks after grafting, regardless of the grafting site. The extensive fibrosis observed does not appear to have a major influence on early follicle development, but its long-term impact must be investigated. The graft environment could be implicated in the preservation of the stroma, as suggested by the lower degree of fibrosis observed in the IM site. Finally, selection of the most appropriate transplantation site for short-term studies should depend on the experimental objectives and technical constraints. 
